Return On Assets of Amphastar Pharmaceuticals, Inc. from 31 Mar 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Amphastar Pharmaceuticals, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2015 to 30 Sep 2025.
  • Amphastar Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Sep 2025 was 6.9%, a 33% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Return On Assets for 2024 was 10%, a 2.4% decline from 2023.
  • Amphastar Pharmaceuticals, Inc. annual Return On Assets for 2023 was 11%, a 16% decline from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Return On Assets for 2022 was 13%, a 33% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Amphastar Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 6.9% -3.4% -33% 01 Jul 2025 30 Sep 2025
Q2 2025 8.5% -2.4% -22% 01 Apr 2025 30 Jun 2025
Q1 2025 9.1% -1.2% -12% 01 Jan 2025 31 Mar 2025
Q4 2024 10% -0.25% -2.4% 01 Oct 2024 31 Dec 2024
Q3 2024 10% -1.9% -16% 01 Jul 2024 30 Sep 2024
Q2 2024 11% -0.39% -3.5% 01 Apr 2024 30 Jun 2024
Q1 2024 10% -2.3% -18% 01 Jan 2024 31 Mar 2024
Q4 2023 11% -2% -16% 01 Oct 2023 31 Dec 2023
Q3 2023 12% +1.3% +12% 01 Jul 2023 30 Sep 2023
Q2 2023 11% -1.9% -14% 01 Apr 2023 30 Jun 2023
Q1 2023 13% +0.54% +4.5% 01 Jan 2023 31 Mar 2023
Q4 2022 13% +3.1% +33% 01 Oct 2022 31 Dec 2022
Q3 2022 11% +5.3% +96% 01 Jul 2022 30 Sep 2022
Q2 2022 13% +12% +704% 01 Apr 2022 30 Jun 2022
Q1 2022 12% +12% +2900% 01 Jan 2022 31 Mar 2022
Q4 2021 9.4% +9.2% +3964% 01 Oct 2021 31 Dec 2021
Q3 2021 5.6% +4.4% +396% 01 Jul 2021 30 Sep 2021
Q2 2021 1.6% +0.95% +138% 01 Apr 2021 30 Jun 2021
Q1 2021 0.4% -8.5% -96% 01 Jan 2021 31 Mar 2021
Q4 2020 0.23% -8.2% -97% 01 Oct 2020 31 Dec 2020
Q3 2020 1.1% -8.1% -88% 01 Jul 2020 30 Sep 2020
Q2 2020 0.69% -9.2% -93% 01 Apr 2020 30 Jun 2020
Q1 2020 8.9% +8.4% +1843% 01 Jan 2020 31 Mar 2020
Q4 2019 8.4% +9.6% 01 Oct 2019 31 Dec 2019
Q3 2019 9.2% +11% 01 Jul 2019 30 Sep 2019
Q2 2019 9.9% +12% 01 Apr 2019 30 Jun 2019
Q1 2019 0.46% +1.3% 01 Jan 2019 31 Mar 2019
Q4 2018 -1.2% -2.2% -220% 01 Oct 2018 31 Dec 2018
Q3 2018 -1.3% -1.4% -2732% 01 Jul 2018 30 Sep 2018
Q2 2018 -1.9% -2.8% -304% 01 Apr 2018 30 Jun 2018
Q1 2018 -0.81% -2.9% -138% 01 Jan 2018 31 Mar 2018
Q4 2017 1% -1.5% -61% 01 Oct 2017 31 Dec 2017
Q3 2017 0.05% -5.1% -99% 01 Jul 2017 30 Sep 2017
Q2 2017 0.92% -2.6% -74% 01 Apr 2017 30 Jun 2017
Q1 2017 2.1% +2% +2162% 01 Jan 2017 31 Mar 2017
Q4 2016 2.5% +3.2% 01 Oct 2016 31 Dec 2016
Q3 2016 5.1% +8.4% 01 Jul 2016 30 Sep 2016
Q2 2016 3.5% +7.3% 01 Apr 2016 30 Jun 2016
Q1 2016 0.09% +2.6% 01 Jan 2016 31 Mar 2016
Q4 2015 -0.71% 01 Oct 2015 31 Dec 2015
Q3 2015 -3.2% 01 Jul 2015 30 Sep 2015
Q2 2015 -3.8% 01 Apr 2015 30 Jun 2015
Q1 2015 -2.5% 01 Jan 2015 31 Mar 2015

Amphastar Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 10% -0.25% -2.4% 01 Jan 2024 31 Dec 2024
2023 11% -2% -16% 01 Jan 2023 31 Dec 2023
2022 13% +3.1% +33% 01 Jan 2022 31 Dec 2022
2021 9.4% +9.2% +3964% 01 Jan 2021 31 Dec 2021
2020 0.23% -8.2% -97% 01 Jan 2020 31 Dec 2020
2019 8.4% +9.6% 01 Jan 2019 31 Dec 2019
2018 -1.2% -2% -247% 01 Jan 2018 31 Dec 2018
2017 0.82% -1.5% -65% 01 Jan 2017 31 Dec 2017
2016 2.4% +3.1% 01 Jan 2016 31 Dec 2016
2015 -0.71% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.